Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

New treatments like JAK inhibitors show promise for reversing alopecia areata.

Regulatory T cells help heal skin and grow hair, and their absence can lead to healing issues and hair loss.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Genetic defects in the glucocorticoid receptor gene can cause conditions with abnormal sensitivity to stress hormones, and other factors may also affect this sensitivity.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Lymphatic vessels are essential for hair follicle growth and skin regeneration.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Genomic approach finds new possible treatments for hair loss.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Melatonin helps regulate hair growth and protects the hair follicle from stress.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Male rats have more somatostatin neurons than females due to testosterone converting to estrogen during early development.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Lowering testosterone speeds up wound healing in male mice.